Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Merkel Cell × Cisplatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 203 Squamous Cell Carcinoma of Head and Neck 141 Head and Neck Neoplasms 121 Nasopharyngeal Carcinoma 99 Lung Neoplasms 97 Esophageal Neoplasms 97 Uterine Cervical Neoplasms 85 Stomach Neoplasms 78 Esophageal Squamous Cell Carcinoma 73 Breast Neoplasms 63 Urinary Bladder Neoplasms 57 Pancreatic Neoplasms 53 Small Cell Lung Carcinoma 52 Carcinoma, Squamous Cell 52 Neoplasms 50 Ovarian Neoplasms 41 Cholangiocarcinoma 41 Oropharyngeal Neoplasms 36 Neoplasm Metastasis 35 Biliary Tract Neoplasms 35 Adenocarcinoma Of Esophagus 32 Recurrence 26 Mesothelioma, Malignant 26 Gallbladder Neoplasms 24 Triple Negative Breast Neoplasms 21 Lymphoma 21 Laryngeal Neoplasms 19 Carcinoma, Transitional Cell 19 Sarcoma 18 Nasopharyngeal Neoplasms 18

Interventions

pembrolizumab 12 avelumab 8 Radiotherapy 8 Nivolumab 7 cemiplimab 4 Radiation 4 Ipilimumab 4 poly ICLC 3 atezolizumab 3 Cyclophosphamide 3 talimogene laherparepvec 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Biopsy 2 veliparib 1 vatalanib 1 tremelimumab 1 tocilizumab 1 temsirolimus 1 sargramostim 1 sapanisertib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06086288 2023-10-17

PANDORA

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡